Exploring Central Sensitization in Pregnant Women

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorGöteborg University

About this trial

Pelvic Girdle Pain (PGP) is reported by 50% of pregnant women and up to 11 years after pregnancy, 10% of women have persistent and per definition chronic PGP. Central (nervous system) sensitization that elicits pain hypersensitivity, may be one explanation.

The overall aim of this study is to explore features of central sensitization in pregnant women and its predictive ability on physical activity, functioning and health in women with PGP. Measurements of central sensitization will be done on two study groups, pregnant women with PGP and healthy controls. To identify women at risk to develop chronic pain in relation to a common pain experience ie PGP in pregnancy, may help us understand if central sensitization early in life explains why women develop chronic pain.

Eligibility criteria

Qualifiers

pregnant (first time pregnant or previous experience of pregnancy)

18 years of age or older

have a single foetus pregnancy

be in gestational weeks 20-30

Disqualifiers

no history of a fracture or malignant disease in the back, pelvis, pelvic floor or hips

no systemic disease of the musculoskeletal or the nervous system

no diseases such as gestational diabetes or diabetes type 1 and 2, hypertension

no obstetric complications

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Göteborg University

Lead sponsor

Vastra Gotaland Region

Collaborator